Douglas Steel, PhD is the Founder of NeuroSense (www.neuro-sense.com). A Translational Scientist, for the past several years he has been working on the development of applications of spectrally-tunable LED arrays as an alternative to prescription drugs for the treatment of neurological and psychiatric conditions.

He is also a serial entrepreneur, having founded or co-founded and managed 6 technology start-up companies over the past 17 years in a number of life science areas. For several years he was an Entrepreneur-in-Residence at the University of Utah.

Doug has over 30 years of experience in pharmaceutical drug design and discovery, and research project management and implementation divided between academia and the pharmaceutical industry. He has received training in medical sciences and neuroscience, basic and applied biotechnology, integrative neuroscience, and brain-environment interactions. He is the author of over 20 publications in scientific journals and books in the areas of drug design, drug discovery, and marine biochemistry. He has also written over 30 technology articles in the popular press.

Doug holds an M.Phil. and PhD in Biomedical Sciences from Columbia University, an MS (Psychobiology, Univ. of Florida), and a BA (Biology/Chemistry, Kalamazoo College). He also held pharmaceutical research positions at The Upjohn Company, CIBA-Geigy, and Syntex Pharmaceuticals.

Doug is a member of the Science Advisory Panel of the IES (Illuminating Engineering Society), and also serves on the Science Advisory Boards of the Midwest Lighting Institute and the LESA Center at RPI (Lighting Enabled Systems and Applications).